Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

141.00
-0.0500-0.04%
Post-market: 141.000.00000.00%19:30 EDT
Volume:2.25M
Turnover:316.09M
Market Cap:269.03B
PE:21.32
High:141.57
Open:141.46
Low:139.95
Close:141.05
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:1.14
T/O Rate:0.12%
Dividend:4.67
Dividend Rate:3.31%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:6.48
PE(LYR):19.72

Loading ...

Sarepta Faces Competitive Pressures Despite Pipeline Updates, RBC Says

MT Newswires Live
·
Aug 07

Correction to Novartis Wins FDA Approval for Expanded Prostate Cancer Treatment Article on July 31

Dow Jones
·
Aug 04

Novartis says FDA approves Pluvicto for PSMA+ metastatic prostate cancer

TIPRANKS
·
Aug 01

Berenberg Bank Remains a Hold on Novartis (NVS)

TIPRANKS
·
Jul 28

Berenberg Lifts Price Target on Novartis to $147 From $141, Keeps Hold Rating

MT Newswires Live
·
Jul 27

Novartis price target raised to CHF 142 from CHF 132 at Citi

TIPRANKS
·
Jul 23

Novartis (NVS) Receives a Sell from Goldman Sachs

TIPRANKS
·
Jul 22

Novartis AG Stock (NVS) Moved Up by 3.42% on Jul 21: Key Drivers Unveiled

TradingKey
·
Jul 22

Movement Alert|Novartis Rises 3.76% in Regular Trading, Q2 Earnings Significantly Beat Expectations Signaling Growth Recovery

Market Focus
·
Jul 21

Novartis Silences Generic Fears With Blowout Quarter, Packed Pipeline

Benzinga Earnings
·
Jul 21

Potential Middle East Ceasefire Lifts US Equity Futures Pre-Bell

MT Newswires Live
·
Jul 21

Novartis Returns to Growth After Key Drugs Offset Patent Expirations

Dow Jones
·
Jul 21

Key Drug Sales Drive Novartis Back to Revenue Growth

Deep News
·
Jul 21

Stocks to Watch: GM, Novartis, Swatch, Micron

Dow Jones
·
Jul 21

Movement Alert|Novartis Rises 3.58% in Pre-Market Trading, Q2 Earnings Significantly Beat Expectations Signaling Growth Recovery

Market Focus
·
Jul 21

Novartis Guidance Points to Slow Second Half

Dow Jones
·
Jul 21

Novartis Q2 Core Earnings Down, Sales Rise

MT Newswires Live
·
Jul 21

Novartis Benefits from Timing Effects That Will Drag Next Results

Dow Jones
·
Jul 21

Movement Alert|Novartis Overnight Rise 3.47%, Q2 Earnings Significantly Beat Expectations Signaling Return to Growth

Market Focus
·
Jul 21

Novartis Beats Expectations, but Guidance Reiteration Surprises

Dow Jones
·
Jul 21